Survival of Mice Receiving Melanoma Transplants Is Promoted by Hydroquinone

25 April 1980

journal article
other
Published by American Association for the Advancement of Science (AAAS) in Science

Vol. 208 (4442) , 408-410
https://doi.org/10.1126/science.7367868

Abstract

In BALB/c female mice with melanoma transplants, the incidence of "takes" is decreased and survival is increased by hydroquinone, a melanocytolytic agent. The mechanism of drug action is suggested to be via DNA. The significant and high degree of positive response to hydroquinone treatment in vivo is encouraging for the clinical management of melanoma with melanocytolytic agents.

Keywords

This publication has 13 references indexed in Scilit:

Hydroxyanisole‐induced regression of the Harding‐Passey melanoma in mice
The Journal of Pathology, 1977
Mechanism of Depigmentation by Hydroquinone
Journal of Investigative Dermatology, 1974
352. Note: Conservatism of the Approximation Σ(O - E) 2 /E in the Logrank Test for Survival Data or Tumor Incidence Data
Published by JSTOR ,1973
PART I. ANALYSIS OF PRESENTING FEATURES OF PROGNOSTIC IMPORTANCE
British Journal of Haematology, 1973
Asymptotically Efficient Rank Invariant Test Procedures
Journal of the Royal Statistical Society. Series A (General), 1972
Evaluation of the Toxicity of the Monoethyl Ether of Hydroquinone for Mammalian Melanocytes and Melanoma Cells
Journal of Investigative Dermatology, 1971
Experimentelle Depigmentierung der Meerschweinchenhaut durch selektiv toxische Wirkung von Hydrochinon-mono thyl ther auf die Melanocyten
Archives of Dermatological Research, 1969
Selective Action of Mercaptoethylamines on Melanocytes in Mammalian Skin
Archives of Dermatology, 1968
Depigmentation of Skin with 4-Isopropylcatechol, Mercaptoamines, and other Compounds*
Journal of Investigative Dermatology, 1968
The Influence of Certain Hormones and Chemicals on Mammalian Pigment Cells**From the Department of Dermatology, Henry Ford Hospital, Detroit, Michigan.
Journal of Investigative Dermatology, 1966